Advancing Skin Health: Experts Call for Consensus Human Skin Cell Atlas
Originally Published 2 years ago — by Pharmacy Times
In August 2023, experts at the Asembia Specialty Pharmacy Summit emphasized the importance of listening to patients and caregivers when treating pediatric atopic dermatitis (AD), a skin condition characterized by inflamed and itchy rashes. Sleep disturbances and anxiety are common among caregivers, highlighting the need for comprehensive care. Meanwhile, a study found that upadacitinib maintained its efficacy for 3 years in patients with psoriatic arthritis, with no new safety concerns identified. Additionally, lebrikizumab showed promising results in improving or clearing the skin of adult and adolescent patients with moderate to severe AD.